Skip to Main Content

Paper Details

Adavosertib with Chemotherapy in Patients with Primary Platinum-Resistant Ovarian, Fallopian Tube, or Peritoneal Cancer: An Open-Label, Four-Arm, Phase II Study.
Clin Cancer Res
38
2022
Author NameAffiliation
Shekhar GhamandeAugusta University
Gottfried E Konecnyuniversity of california los angeles
Daniel SpitzSarah Cannon Research Institute
Daniel SpitzFlorida Cancer Specialists & Research Institute
Zhongwu Lai
  • 1 - 5

Datasets

Release 1.2